Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$473,908
+$18,272 QoQ
Shares Held
1,866
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#3,754
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pacific Center for Financial Services holds $1,504,810 across 13 Drug Manufacturers - General names. JNJ ranks #1 (31.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
1,866 | $473,908 | |
| 2 | MRK |
Merck & Co., Inc.
|
2,026 | $260,341 | |
| 3 | ABBV |
AbbVie Inc.
|
935 | $235,283 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,757 | $158,858 | |
| 5 | PFE |
Pfizer Inc
|
4,775 | $114,982 | |
| 6 | AMGN |
Amgen Inc
|
264 | $95,599 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
612 | $77,320 | |
| 8 | AZN |
Astrazeneca PLC
|
175 | $33,183 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $473,908 | 1,866 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $455,636 | 1,864 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $324,083 | 1,566 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $290,367 | 1,566 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $238,748 | 1,563 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $260,700 | 1,572 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $226,908 | 1,569 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $253,785 | 1,566 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $228,448 | 1,563 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $246,618 | 1,559 | Shares | Sole | 2024-05-20 | |
| 2023-12-31 | $243,887 | 1,556 | Shares | Sole | 2024-02-20 | |
| 2023-09-30 | $241,879 | 1,553 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $124,140 | 750 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $115,785 | 747 | Shares | Sole | 2023-05-16 | |
| 2022-09-30 | $151,761 | 929 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $164,019 | 924 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $160,747 | 907 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $154,476 | 903 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $145,027 | 898 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $147,277 | 894 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $145,614 | 886 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $107,647 | 684 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $77,417 | 520 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $47,111 | 335 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $50,222 | 383 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||